Key opportunities in the buprenorphine patch market include enhancing opioid stewardship, leveraging digital prescribing, securing robust supply chains, and aligning clinical protocols with payer and ...

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...

Buprenorphine may be as effective as conventional analgesia in older adults with acute pain, with reduced opioid consumption and breakthrough analgesia. In older adults, buprenorphine was found to ...

Pain was scored from 0 to 10 on a numeric rating scale. Secondary outcomes included achievement of at least a 30% reduction in pain from baseline levels, hospital readmission for pain within 30 days ...

Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm ...